Global USP15 Antibody Market Growth (Status and Outlook) 2025-2031

The global USP15 Antibody market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of % from 2025 to 2031.

USP15 Antibody (2D5) is a mouse monoclonal IgG1 κ, cited in 11 publications, provided at 100 µg/ml, raised against recombinant USP15 of human origin. Recommended for detection of USP15 of mouse, rat and human origin by WB, IP, IF and ELISA.

Growing patient base, launch of USP15 antibody drugs, increasing penetration of antibody drugs, and continuous regulation across the biopharmaceutical industry are the key factors driving the increase in USP15 antibody market revenue.

ReportPrime's newest research report, the “USP15 Antibody Industry Forecast” looks at past sales and reviews total world USP15 Antibody sales in 2024, providing a comprehensive analysis by region and market sector of projected USP15 Antibody sales for 2025 through 2031. With USP15 Antibody sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world USP15 Antibody industry.

This Insight Report provides a comprehensive analysis of the global USP15 Antibody landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on USP15 Antibody portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global USP15 Antibody market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for USP15 Antibody and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global USP15 Antibody.

This report presents a comprehensive overview, market shares, and growth opportunities of USP15 Antibody market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Monoclonal
• Polyclonal

Segmentation by Application:

• Immunochemistry (IHC)
• Immunofluorescence (IF)
• Immunoprecipitation (IP)
• Western Blot (WB)
• ELISA
• Others

Market by Region:

• Americas
• APAC
• Europe
• Middle East & Africa

Company's Coverage:

• Thermo Fisher Scientific
• ProSci
• Proteintech Group
• Bethyl Laboratories
• Aviva Systems Biology
• RayBiotech
• LifeSpan BioSciences
• Abcam
• OriGene Technologies
• Novus Biologicals
• Enzo Life Sciences
• Cell Signaling Technology
• Abnova Corporation
• Affinity Biosciences
• Santa Cruz Biotechnology
• Biobyt
• Jingjie PTM BioLab
• Wuhan Fine

Key Questions Addressed in this Report: